Biovie Inc Stock Investor Sentiment

BIVI Stock  USD 1.67  0.02  1.21%   
Under 65% of Biovie's investor base is looking to short. The analysis of the overall investor sentiment regarding Biovie Inc suggests that many traders are alarmed. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
  

Biovie Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at seekingalpha.com         
BioVie announces 1-for-10 reverse stock split
seekingalpha News
over six months ago at news.google.com         
BioVie announces reverse stock split decision - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
BioVie Inc. Short Interest Update - Defense World
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 5984 shares by Berman Richard J of Biovie at 5.8125 subject to Rule 16b-3
Macroaxis News
over six months ago at accesswire.com         
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on...
news
over six months ago at news.google.com         
BioVie Inc. Short Interest Update - Defense World
Google News at Macroaxis
over six months ago at simplywall.st         
Despite Hitting US0.40, BioVie Insiders Still Sold Too Soon
Simply Wall St News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Do Cuong V of 227000 shares of Biovie at 0.474 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by Palumbo Joseph M of 624 shares of Biovie subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
Yahoo News
over six months ago at globenewswire.com         
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Pa...
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Pa...
Yahoo News
over six months ago at benzinga.com         
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Pa...
benzinga news
over six months ago at news.google.com         
BioVie Inc. Short Interest Update - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Join BioVies Exclusive Live Investor Webinar and QA Session on June 26
Yahoo News
Far too much social signal, news, headlines, and media speculation about Biovie that are available to investors today. That information is available publicly through Biovie media outlets and privately through word of mouth or via Biovie internal channels. However, regardless of the origin, that massive amount of Biovie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biovie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biovie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biovie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biovie alpha.

Biovie Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
BioVies Upcoming Parkinsons Disease Clinical Trial is Fully Funded
11/04/2024
2
Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3
11/07/2024
3
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
11/20/2024
4
Acquisition by Do Cuong V of 104502 shares of Biovie at 1.9 subject to Rule 16b-3
12/20/2024
5
Acquisition by Rogich Sigmund of 123400 shares of Biovie at 5.04 subject to Rule 16b-3
12/27/2024
6
BioVie Leaders Sued for Stock Slips on Clinical Trial Misconduct - Bloomberg Law
12/31/2024
7
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, ...
01/13/2025

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities